CellSource Co., Ltd.

TSE:4880.T

1174 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 1,113.711,054.1571,173.5161,104.4161,235.5161,111.0821,059.531,400.8421,175.967876.103820.917817.967761.14720.442622.683543.514425.672441.861444.428439.385
Cost of Revenue 418.721393.073409.709350.729346.833347.914280.067374.028334.789261.126239.585242.335222.773209.662173.437162.066146.303160.702127.448129.23
Gross Profit 694.989661.084763.807753.687888.683763.168779.4631,026.814841.178614.977581.332575.632538.367510.78449.246381.448279.369281.159316.98310.155
Gross Profit Ratio 0.6240.6270.6510.6820.7190.6870.7360.7330.7150.7020.7080.7040.7070.7090.7210.7020.6560.6360.7130.706
Reseach & Development Expenses 022.50715.45913.52515.87216.19226.86421.67522.63826.06117.18811.11821.92122.7110100007
General & Administrative Expenses 0008200082000650006800066
Selling & Marketing Expenses 00010300010000093000122000198
SG&A 588.338562.963542.486561.876488.936438.925401.311372.851370.526342.541319.767250.783260.214245.813269201214218192198
Other Expenses 0106.975-0.01720.0950.437455.117428.175394.522393.164368.602336.9552.062-0.02417.481218.6830.0230.0080.0484.939
Operating Expenses 588.338585.47557.945575.397504.808455.117428.175394.522393.164368.602336.955261.896282.135268.524269.024218.683214.426217.938192.354211.112
Operating Income 106.65175.614205.862178.286383.875308.051351.287632.287448.014246.375244.376313.731256.234242.255180.221162.76164.94463.222124.62499.04
Operating Income Ratio 0.0960.0720.1750.1610.3110.2770.3320.4510.3810.2810.2980.3840.3370.3360.2890.2990.1530.1430.280.225
Total Other Income Expenses Net 2.936151.4426.856-23.18241.89511.201-11.7314.7062.6734.6460.5620.939-0.01412.4040.5920.023-2.0080.426-1.189-18.617
Income Before Tax 109.587227.056212.718155.104425.77319.252339.556636.993450.687251.021244.938314.675256.219254.66180.813162.78862.93563.648123.43680.427
Income Before Tax Ratio 0.0980.2150.1810.140.3450.2870.320.4550.3830.2870.2980.3850.3370.3530.290.30.1480.1440.2780.183
Income Tax Expense 35.35670.98168.816-92.9160.694125.234123.512208.276169.95198.39889.17191.48196.79998.99167.747.09222.99822.72945.90626.546
Net Income 74.231156.076143.901248.004265.077194.017216.044428.716280.736152.624155.766223.195159.419155.67113.112115.69739.93740.91977.52953.881
Net Income Ratio 0.0670.1480.1230.2250.2150.1750.2040.3060.2390.1740.190.2730.2090.2160.1820.2130.0940.0930.1740.123
EPS 3.757.887.2712.8814.0310.3811.5622.9415.038.188.3612.18.648.446.136.272.172.314.373.04
EPS Diluted 3.737.847.2312.7813.810.111.2422.3114.627.958.1112.18.648.445.896.272.172.314.083.04
EBITDA 134.671106.004231.512158.242388.966318.017334.313648.198450.687251.023244.947316.719256.249254.699180.861162.84663.00263.724123.52180.427
EBITDA Ratio 0.1210.1010.1970.1430.3150.2860.3160.4630.3830.2870.2980.3870.3370.3540.290.30.1480.1440.2780.183